Lamotrigine

StatusCommercial
Therapeutic cat.Neurology
Polymorphic formAnhydrous monoclinic
CAS No.84057-84-1
Reference Product
Injectable Form
EU DMF readinessCheckbox
CEPCheckbox
CHINESE  DMFCheckbox
JAPANESE DMFCheckbox
KOREAN  DMFCheckbox
CANADIAN  DMFCheckbox
CADIFACheckbox
US DMF readinessCheckbox
OEB No.
Samples

Drug description

Lamotrigine is an anti-epileptic medication, also called an anticonvulsant. Lamotrigine is used alone or with other medications to treat epileptic seizures in adults and children. Lamotrigine is also used to delay mood episodes in adults with bipolar disorder (manic depression). Immediate-release lamotrigine can be used in children as young as 2 years old when it is given as part of a combination of seizure medications. However, this form should not be used as a single medication in a child or teenager who is younger than 16 years old. Extended-release lamotrigine is for use only in adults and children who are at least 13 years old. Lamotrigine may also be used for purposes not listed in this medication guide.

Polpharma API

Disclaimer

Products protected by patents (SPC) in Poland are developed solely for the purpose of Regulatory Submissions or R&D purposes intended to support Regulatory Submissions. These products are not offered for sale or made available in countries where such products are subject to patent (SPC) protection and where the offer for sale or any related activity constitutes patent infringement. It is within the buyer’s responsibility and liability to check the patent situation of the product in the import market(s).

Have a question?
Our specialists will be happy to guide you through our cooperation process.
Contact us